Fagron NV Company Description

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide.

It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.

Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort.

In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy.

The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Fagron NV

Country	Belgium
Founded	1990
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	3,282
CEO	Rafael Padilla

Contact Details

Address: Venecoweg 20A Nazareth, 9810 Belgium
Phone	32 8 001 28 80
Website	fagron.com

Stock Details

Ticker Symbol	FAGR
Exchange	Euronext Brussels
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	BE0003874915
SIC Code	5047

Key Executives

Name	Position
Rafael Padilla	Chief Executive Officer and Executive Director
Karin de Jong	Chief Financial Officer and Executive Director
Vera Bakker	Chief Operating Officer
Karen Berg	Global Investor Relations Manager
Johan Verlinden	Head of Legal, Mergers and Acquisitions